The purpose of this study is to determine the clinical efficacy and neuro-cognitive mechanisms of Gaze-Contingent Usic Reward Therapy for social anxiety disorder, compared with treatment with SSRIs or waitlist control.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline - the Liebowitz Social Anxiety Scale - Diagnostic Interview scores
Timeframe: 6 weeks into intervention, 1 week after intervention completion